METHOD DEVELOPMENT FOR THE DETERMINATION OF NIFEDIPINE AND PHENYTOIN IN HUMAN GINGIVAL CREVICULAR FLUID AND PLASMA BY HPLC


Creative Commons License

Dinçel A.

Kromatografi XX. Uluslararası Katılımlı, Ankara, Türkiye, 24 - 25 Şubat 2022

  • Yayın Türü: Bildiri / Yayınlanmadı
  • Basıldığı Şehir: Ankara
  • Basıldığı Ülke: Türkiye
  • Lokman Hekim Üniversitesi Adresli: Evet

Özet

One of the widely known side effects of nifedipine and phenytoin is gingival overgrowth. The aim of this study is method development for determination of nifedipine and phenytoin concentration in gingival crevicular fluid (GCF) and plasma by HPLC. And to develop analysis methods to determine whether there is a relationship between plasma/GCF levels and nifedipine, phenytoin levels.  Separation of nifedipine from GCF was performed by Microsphere, C18 (100 x 4.6 mm, particle size 3 mm) analytical column and methanol, sodium acetate (pH=4.0, 10 mM) (60:40, v/v) containing mobile phase at 0.8 ml/min. Detection of nifedipine and nitrendipine (internal standard, 0.5 mg/ml) was performed by UV/Vis detector at 235 nm. GCF samples were extracted by using a mixture of methanol and water (50:50, v/v). Plasma nifedipine content were extracted by using a mixture of hexane and dichloromethane. The calibration curve for nifedipine was linear over the concentration range of 0.01-0.5 mg/ml. The mean recovery (±SD) from GCF was 99.05±3.72 % for nifedipine at a concentration of 0.1 mg/ml (n=6). The mean recovery (±SD) from plasma was 102.03±5.62 % for nifedipine at a concentration of 0.1 mg/ml (n=6).

Separation of phenytoin from GCF was performed by XTerra, C18 (250 x 4.6 mm, particle size 5 mm) analytical column and acetonitrile, K2HPO4 (pH=5.0, 20 mM) (30:70, v/v) containing mobile phase at 1.2 ml/min. Phenytoin and mephenytoin (as an internal standard, 5 mg/ml) were detected by UV/Vis detector at 240 nm. GCF samples were extracted by using a mixture of acetonitrile and water (50:50, v/v). Plasma samples were extracted by using acetonitrile. The calibration curve for phenytoin was linear over the concentration range of 0.02-5 mg/ml. The mean recovery (±SD) from GCF was 101.15±4.12 % for phenytoin at a concentration of 1 mg/ml (n=6). The mean recovery (±SD) from plasma was 105.22±3.17 % for phenytoin at a concentration of 1 mg/ml (n=6). Consequently, this study describes a simple, sensitive, and practical HPLC-UV/Vis method which permits determination of nifedipine and phenytoin in human gingival crevicular fluid and plasma samples.